To support the strategic goals of the Oncology Business by driving optimal patient access for our immuno-oncology medicines. This role directly impacts the ability to achieve business objectives on a global basis by providing strategic guidance and robust evidence development relevant to achieve optimal global patient access by demonstrating the value of our immuno-oncology medicines. The HEOR Director will be responsible for independently leading the evidence generation strategy at a Global level, including oversight and development of evidence generation and dissemination of technical deliverables that support the value of avelumab and other early immuno-oncology medicines. She/he will function with a one Patient and Health Impact (PHI) mindset and will work in a closely with the Market Access (MA) and the Cross-Functional Leadership Team (CFLT) to ensure there is a single and coordinated view on strategy and delivery for PHI to the Oncology business. This position resides within the PHI HEOR group, reporting to the Global HEOR, Immuno-Oncology Team Lead. Responsibilities: Lead the development of Health Economics & Outcomes Research (HEOR) strategy to support the value of assets in the Oncology Business Unit (BU) in close partnership with the cross-functional matrix team. Lead the execution of HEOR studies and projects (including Non-Interventional Studies, registries, etc) in alignment with the global O&E strategy and demonstrate the value proposition for assets in the Oncology BU. Incorporate humanistic and economic endpoints into clinical trials across all phases of product development to build comprehensive trial-based evidence in line with overall medical strategy for the assets and to ensure global reimbursement and access requirements. Provide strategic input in the selection of relevant patient population and comparators within clinical trials to enable successful negotiations, reimbursement, and appropriate patient access with global payer and regulatory decision makers. Development and validation of new Patient Reported Outcomes measures as appropriate for inclusion across clinical trials, registries, and prospective real world studies. Identify opportunities to partner with Oncology BU external customers to conduct HEOR projects in support of asset strategies Lead the timely development of launch and post launch deliverables including global value dossiers (GVDs), evidence blueprints, economic models, and innovative tools to successfully support global launch and post-launch reimbursement and access requirements in conjunction with the regions/countries. Lead the coordination of input from local country/regional teams on evidence needs and ensure that the input is appropriately incorporated to develop and integrated evidence strategy to support global market access needs at launch and through lifecycle. Develop real world evidence generation strategies and flawlessly execute studies (e.g., burden of illness studies, epidemiology studies, etc). Develop strategic partnerships and research collaborations with key external experts, healthcare policy makers, payers, and various academic and community oncology settings to support asset strategies. Provide strategic guidance and content guidance in reimbursement (re)negotiations for Pfizer products. Lead the development of appropriate data dissemination plans and communicate evidence generated via publications and conference presentations. Qualifications: Minimum Masters degree (MSc, MPH) in health services research, public health, epidemiology, or health economics with a preferred Doctoral degree (PhD, DrPH, ScD) in health services research, public health, epidemiology, or health economics. Minimum 8 years' experience in health outcomes and related fields, 5 of which are as part of global health economics and/or outcomes research teams in a pharmaceutical company. Strong working knowledge of the technical and methodological aspects of registries and observational study design and implementation. Capable of independently managing complex registry and non-interventional study projects. Strong methodological skills (study design, data analysis and interpretation) in cancer epidemiology or health services research is required In depth understanding of Pharmacoeconomics and Health-related Quality of Life Knowledge and experience in the oncology therapeutic area is preferred Experience with HTA organizations such as NICE, SMC, PBAC is desirable Excellent interpersonal skills required: ability to understand and respond to multiple internal and external customers Excellent oral and written English communication skills required Strong project management abilities (contracting, budgeting, vendor management) essential. Demonstrated ability to manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities Ability to influence key members of medical and commercial teams constructively and without conflict Skilled in functioning within a matrix organization where managing through influence is required Organized and detail oriented with the ability to anticipate needs and to work proactively to prioritize & address/resolve Change oriented, comfortable responding to unexpected demands with tight timelines; team player. EEO & Employment Eligibility Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer. Sunshine Act Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative. Additional Offer Details: Last Date to Apply for Job: December 8, 2017 Additional Location Information: This position can be based in New York, NY or Collegeville PA Eligible for Employee Referral Bonus - Yes Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.